Deutsch
A A A
Bereichsnavigation

Previous
RHÖN-KLINIKUM AG RHÖN-KLINIKUM AG | 04/15/2016

RHÖN-KLINIKUM AG: Results Press Conference in Frankfurt am Main on 15th April 2016

  • 765,109 patients treated
  • Revenues amount to € 1.11 billion
  • EBITDA stands at € 154.2 million
  • Net consolidated profit amounts to € 87.4 million
  • Financial figures affected by special influences
  • Dividend proposal in the amount of € 0.80 per share
  • Outlook for 2016: Revenues between € 1.17 billion and € 1.20 billion, EBITDA between € 155 million and € 165 million

 

Bad Neustadt / Saale, 15th April 2016

A total of 765,109 patients were treated in the RHÖN-KLINIKUM AG hospitals in the past year. Just like the business development the number of patients was also still strongly influenced by the sale of a total of 43 hospitals which was completed in financial year 2014, even if to a significantly less extent. The group portfolio now consists of five facilities offering maximum medical care in all our locations with a total of roughly 5,300 beds.

Against this background RHÖN-KLINIKUM AG achieved revenues of € 1.11 billion for the past financial year. Earnings before interest, taxes, depreciation and amortisation (EBITDA) stood at € 154.2 million while net consolidated profit was € 87.4 million.

“Our corporate group continued its progress in the first full financial year after the strategic reorientation. We achieved a very satisfactory result and we also continued to promote our vision for the future, “ CEO Dr. Martin Siebert said. “We have a pioneering role with our various schemes to digitalise medical care, such as working together with IBM to design a data‑assisted patient navigation system or setting up our own company to promote innovative start-up projects in the area of medicine. As a company providing maximum medical care we are well-prepared to generate attractive growth prospects and additional earnings with the campus concept designed to stimulate a network of healthcare particularly in rural areas.”

 

Share Repurchase Scheme, Larger Board of Management and Dividend Proposal

After a first phase in the autumn of 2014 the shareholders again had the opportunity in the last financial year to offer their shares to the company through a share repurchase programme with subsequent capital reduction. At the end of the scheme on 8th October 2015 the public purchase offer was accepted for a total of 6,519,390 RHÖN-KLINIKUM shares at a share price of € 25.54 which corresponds to approx. 9 percent of the total share capital issued on the cut-off date and a volume of approx. € 167 million. With its new financial structure the corporate group can now take account of the requirements of resource management orientated to capital costs and is therefore in a better position to be able to take advantage of business opportunities for further development.

The company’s Board of Management was enlarged with effect from 1st January 2016. Prof. Dr. Bernd Griewing, spokesperson for the Medical Board and Medical Director of the Neurological Clinic in Bad Neustadt, was appointed to the executive body by the Supervisory Board as the Chief Medical Officer (CMO) alongside Dr. Martin Siebert (CEO), Jens‑Peter Neumann (CFO) and Martin Menger (COO). The departmental responsibilities of the Board of Management were also modified and the terms of the service agreements of the Board of Management standardised. All the members received a five-year agreement, each starting on 1st January 2016.

The Board of Management and Supervisory Board shall propose to this year’s ordinary Annual General Meeting on 8th June in Frankfurt the distribution of the net consolidated profit in the form of a dividend in the amount of € 0.80 per non-par share to the shareholders.

 

Employment

As of 31st December 2015 a total of 15,654 employees was employed in the corporate facilities. The hospitals are each among the largest employers of their respective regions.

 

Outlook for 2016

For the current financial year 2016 the company expects revenues of € 1.17 billion to € 1.20 billion and earnings before interest, tax, depreciation and amortization (EBITDA) of between € 155 million and € 165 million. Positive and negative one-off effects, the size of which will be a low to medium two-digit million figure, will continue to influence the corporate results during this financial year as well and will partially cancel each other out. They mainly result from handling the transaction with Fresenius/Helios, the initial consolidation and integration of the municipal hospital in Bad Neustadt, special budgets for innovation and e-health, unresolved accounting issues and setting up a substantial out-patient clinic at the university hospital in Marburg.

„With our focus on providing maxium medical care and excellent hospital nursing as well as utilising medical innovations one thing will not change: the patient will continue to remain at the centre of all our actions in the future. Following its reorientation RHÖN-KLINIKUM AG will still offer its services to all patients, irrespective of whether they have statutory or private health insurance,” Dr. Martin Siebert stated.